Blijlevens NMA - Search Results

1

Transporter-Mediated Cellular Distribution of Tyrosine Kinase Inhibitors as a Potential Resistance Mechanism in Chronic Myeloid Leukemia.

Verhagen NE, Koenderink JB, Blijlevens NMA, Janssen JJWM, Russel FGM. Verhagen NE, et al. Among authors: blijlevens nma. Pharmaceutics. 2023 Oct 26;15(11):2535. doi: 10.3390/pharmaceutics15112535. Pharmaceutics. 2023. PMID: 38004514 Free PMC article. Review.

2

The Development of a Web-Based, Patient-Centered Intervention for Patients With Chronic Myeloid Leukemia (CMyLife): Design Thinking Development Approach.

Ector GI, Westerweel PE, Hermens RP, Braspenning KA, Heeren BC, Vinck OM, de Jong JJ, Janssen JJ, Blijlevens NM. Ector GI, et al. J Med Internet Res. 2020 May 15;22(5):e15895. doi: 10.2196/15895. J Med Internet Res. 2020. PMID: 32412424 Free PMC article.

3

Response and Adherence to Nilotinib in Daily practice (RAND study): an in-depth observational study of chronic myeloid leukemia patients treated with nilotinib.

Boons CCLM, Timmers L, Janssen JJWM, Westerweel PE, Blijlevens NMA, Smit WM, Bartelink IH, Wilschut JA, Swart EL, Hendrikse NH, Hugtenburg JG. Boons CCLM, et al. Among authors: blijlevens nma. Eur J Clin Pharmacol. 2020 Sep;76(9):1213-1226. doi: 10.1007/s00228-020-02910-3. Epub 2020 Jun 2. Eur J Clin Pharmacol. 2020. PMID: 32488333 Free PMC article.

4

Primary therapy and relative survival among elderly patients with chronic myeloid leukemia: a population-based study in the Netherlands, 1989-2017.

Ector GICG, Visser O, Westerweel PE, Janssen JJWM, Blijlevens NMA, Dinmohamed AG. Ector GICG, et al. Among authors: blijlevens nma. Leukemia. 2020 Dec;34(12):3408-3412. doi: 10.1038/s41375-020-0902-1. Epub 2020 Jun 8. Leukemia. 2020. PMID: 32513966 No abstract available.

5

Fatigue in chronic myeloid leukemia patients on tyrosine kinase inhibitor therapy: predictors and the relationship with physical activity.

Janssen L, Blijlevens NMA, Drissen MMCM, Bakker EA, Nuijten MAH, Janssen JJWM, Timmers S, Hopman MTE. Janssen L, et al. Among authors: blijlevens nma. Haematologica. 2021 Jul 1;106(7):1876-1882. doi: 10.3324/haematol.2020.247767. Haematologica. 2021. PMID: 32616528 Free PMC article.

6

Correction: Primary therapy and relative survival among elderly patients with chronic myeloid leukemia: a population-based study in the Netherlands, 1989-2017.

Ector GICG, Visser O, Westerweel PE, Janssen JJWM, Blijlevens NMA, Dinmohamed AG. Ector GICG, et al. Among authors: blijlevens nma. Leukemia. 2020 Dec;34(12):3440. doi: 10.1038/s41375-020-01040-0. Leukemia. 2020. PMID: 32989222

7

Conditional relative survival among adult patients with chronic myeloid leukemia in the tyrosine kinase inhibitor era: a population-based study in the Netherlands.

Ector GICG, Visser O, Posthuma EFM, Westerweel PE, Janssen JJWM, Blijlevens NMA, Dinmohamed AG. Ector GICG, et al. Among authors: blijlevens nma. Leukemia. 2021 Nov;35(11):3291-3294. doi: 10.1038/s41375-021-01174-9. Epub 2021 Feb 18. Leukemia. 2021. PMID: 33603145 No abstract available.

8

The evolution of the loss of life expectancy in patients with chronic myeloid leukaemia: a population-based study in the Netherlands, 1989-2018.

Maas CCHM, van Klaveren D, Ector GICG, Posthuma EFM, Visser O, Westerweel PE, Janssen JJWM, Blijlevens NMA, Dinmohamed AG. Maas CCHM, et al. Among authors: blijlevens nma. Br J Haematol. 2022 Mar;196(5):1219-1224. doi: 10.1111/bjh.17989. Epub 2021 Dec 5. Br J Haematol. 2022. PMID: 34865221 Free PMC article.

9

A retrospective observational research study to describe the real-world use of bosutinib in patients with chronic myeloid leukemia in the United Kingdom and the Netherlands.

Claudiani S, Janssen JJWM, Byrne J, Smith G, Blijlevens N, Raghavan M, Smith M, Clark RE, Mclain-Smith S, Carter AM, Milojkovic D, Apperley JF. Claudiani S, et al. Eur J Haematol. 2022 Jul;109(1):90-99. doi: 10.1111/ejh.13775. Epub 2022 May 17. Eur J Haematol. 2022. PMID: 35403752 Free PMC article.

10

Treatment patterns and clinical outcomes of asciminib in a real-world multiresistant chronic myeloid leukemia patient population.

Kockerols CCB, Janssen JJWM, Blijlevens NMA, Klein SK, Van Hussen-Daenen LGM, Van Gorkom GGY, Smit WM, Van Balen P, Biemond BJ, Cruijsen MJ, Corsten MF, Te Boekhorst PAW, Koene HR, Van Sluis GL, Cornelissen JJ, Westerweel PE. Kockerols CCB, et al. Among authors: blijlevens nma. Haematologica. 2023 Jan 1;108(1):240-244. doi: 10.3324/haematol.2022.281386. Haematologica. 2023. PMID: 36073515 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

262 results

Search Page